Concentra Group Confidentially Submits Draft Registration Statement On Form S-1 With SEC For IPO
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 18 2024
0mins
Source: Business Insider
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SEM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SEM
Wall Street analysts forecast SEM stock price to rise
4 Analyst Rating
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 16.490
Low
17.00
Averages
18.75
High
21.00
Current: 16.490
Low
17.00
Averages
18.75
High
21.00
About SEM
Select Medical Holdings Corporation operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. Its segments include Critical Illness Recovery Hospital, Rehabilitation Hospital, and Outpatient Rehabilitation. Critical Illness Recovery Hospital segment consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. It operates the majority of its critical illness recovery hospitals as a hospital within a hospital (an HIH). Rehabilitation Hospital segment serves patients that require intensive physical rehabilitation care. Outpatient Rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. It operates around 105 critical illness recovery hospitals in 29 states, 36 rehabilitation hospitals in 14 states, and 1,922 outpatient rehabilitation clinics in 39 states and the District of Columbia.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Merger Investigation: Bleichmar Fonti & Auld LLP is investigating potential breaches of fiduciary duties by Select Medical Holdings Corporation's board and senior management in connection with the company's pending sale for $16.50 per share, which may adversely affect shareholder interests.
- Shareholder Vote Schedule: The merger has been approved by a special committee of Select Medical's board, with a shareholder vote scheduled for June 26, 2026, which could limit shareholders' ability to investigate the fairness of the merger if approved.
- Executive Stock Arrangement: Post-merger, co-founder Robert A. Ortenzio and Senior Executive Vice President Martin F. Jackson are allowed to
See More
- Board Investigation: Bleichmar Fonti & Auld LLP is investigating Select Medical Holdings Corporation's board and senior management for potential breaches of fiduciary duties to shareholders in connection with the pending acquisition at $16.50 per share, which may impact shareholder rights.
- Acquisition Details: On March 2, 2026, Select Medical announced an agreement to be acquired by a consortium led by co-founder Robert A. Ortenzio and Senior Executive Vice President Martin F. Jackson, with all public shareholders' stock being cashed out in the transaction.
- Shareholder Voting Schedule: The acquisition requires approval from Select Medical's shareholders, with a vote scheduled for June 26, 2026; if approved, the merger could close shortly thereafter, potentially limiting shareholders' ability to investigate the fairness of the deal.
- Legal Options: Current shareholders are encouraged to submit their information to BFA to explore legal options, with the firm offering representation on a contingency fee basis, indicating a commitment to protecting shareholder interests.
See More
- Potential Fiduciary Breach: Bleichmar Fonti & Auld LLP is investigating Select Medical Holdings' board and senior management for possible breaches of fiduciary duties to shareholders in connection with the company's pending sale at $16.50 per share, which could adversely affect shareholder interests.
- Acquisition Agreement Details: On March 2, 2026, Select Medical announced an acquisition agreement with a consortium led by co-founder Robert A. Ortenzio and other executives, which will result in shareholders losing all stock holdings in exchange for cash.
- Shareholder Voting Arrangement: The acquisition requires shareholder approval, with a vote scheduled for June 26, 2026, and if successful, it may limit shareholders' ability to investigate the fairness of the transaction, potentially impacting their decision-making.
- Legal Options Advisory: BFA encourages current shareholders to submit their information to explore legal options, with all representation on a contingency fee basis, indicating BFA's commitment to protecting shareholder rights.
See More
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating Select Medical Holdings Corporation's sale to a consortium led by executives at $16.50 per share, raising concerns about potential violations of shareholder rights and urging shareholders to understand their options.
- Merger Scrutiny: The merger of Envirotech Vehicles, Inc. with AZIO AI Corp. is also under investigation, with Halper Sadeh LLC encouraging Envirotech shareholders to reach out to learn about their legal rights, ensuring they are not overlooked during the merger process.
- Real Estate Transaction Review: The sale of Sila Realty Trust, Inc. to Blue Owl Real Estate Capital LLC for $30.38 per share is similarly scrutinized, with Halper Sadeh LLC potentially seeking increased compensation and additional disclosures to protect shareholder interests.
- Legal Fee Arrangement: Halper Sadeh LLC offers legal services on a contingency fee basis, meaning shareholders do not have to pay out-of-pocket legal fees when addressing these matters, ensuring all shareholders can defend their rights without financial burden.
See More
- Shareholder Rights Protection: Monteverde & Associates is investigating the transaction between AvalonBay Communities, Inc. and Equity Residential, where AvalonBay shareholders are expected to receive 2.793 shares of Equity Residential common stock for each share held, impacting shareholder equity structure significantly.
- Merger Impact Analysis: Following the merger, Equity Residential shareholders will own approximately 48.8% of the combined entity, a shift that could alter market dynamics and influence investor strategies moving forward.
- Cash Acquisition Proposal: Shareholders of Select Medical Holdings Corporation are expected to receive $16.50 per share in cash, with a shareholder vote scheduled for June 26, 2026, providing immediate cash returns to investors and enhancing shareholder value.
- Real Estate Transaction Dynamics: Sila Realty Trust, Inc. shareholders are anticipated to receive $30.38 in cash per share, with voting also set for June 26, 2026, further driving consolidation and growth in the real estate market.
See More
- Acquisition Price Controversy: Select Medical Holdings Corp. announced a buyout at $16.50 per share, while analysts maintained a price target of $19.00, indicating the buyout price may undervalue the shares, potentially impacting shareholder returns.
- Legal Investigation Initiated: Kaskela Law is investigating whether the transaction is fair and provides sufficient value to shareholders, and if company executives breached fiduciary duties, which could lead to legal repercussions and affect the company's reputation.
- Shareholder Rights Protection: Select Medical shareholders are encouraged to contact Kaskela Law for additional compensation and legal support, highlighting the importance of shareholder rights and potentially prompting more legal actions from affected investors.
- Investor Compensation Potential: Kaskela Law has recovered over $500 million for investors since 2020, showcasing its successful track record in securities fraud and M&A litigation, which may attract more affected shareholders to participate in the investigation.
See More











